微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 11.5% | 9.11% | 134.69% | 19/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | 4.9% | 48.48% | 105.88% | 35/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 2.38% | -5.18% | -62.1% | 44/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 6.28% | 149.21% | -40.42% | 49/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 10.54% | 85.56% | 219.39% | 22/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 3.3% | 100% | 31.47% | 59/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.51% | -32.35% | -0.4% | 41/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 2.52% | 1580% | -55.63% | 81/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 5.68% | 79.75% | 244.24% | 64/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.65% | -2.37% | -55.53% | 92/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.71% | 231.25% | 2373.33% | 20/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 0.15% | -97.23% | -95.25% | 103/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.16% | 7.12% | 86.98% | 90/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.69% | 19.01% | 50.89% | 90/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.12% | -5.08% | -79.3% | 84/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 5.41% | -1.81% | 83.39% | 72/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.95% | 18.47% | 107.75% | 86/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.42% | 46.39% | 20.34% | 96/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.18% | 55.26% | -78.58% | 87/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 5.51% | 15.76% | 121.29% | 75/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 2.49% | -3.86% | 156.7% | 100/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 0.97% | 8.99% | 27.63% | 110/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.76% | -16.48% | -84.03% | 101/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 4.76% | -10.02% | 83.78% | 87/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 2.59% | 3.6% | 191.01% | 89/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.89% | -43.67% | -2.2% | 103/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 0.91% | -14.95% | -82.8% | 71/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 5.29% | 87.59% | 111.6% | 85/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.5% | 38.12% | 58.23% | 92/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 1.58% | -30.7% | 47.66% | 91/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.07% | 5.94% | -62.06% | 85/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 2.82% | -70% | 55.8% | 104/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.81% | -69.11% | -20.61% | 92/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.28% | -37.19% | 125.74% | 78/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.01% | 1% | -89.26% | 76/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 9.4% | -48.66% | 60.41% | 52/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.86% | 2% | 61.43% | 56/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 3.63% | -61.83% | 263% | 67/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1% | 2% | -94.54% | 62/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 18.31% | -31.09% | 92.53% | 25/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 9.51% | 2% | -64.21% | 15/159 | 3.56% | ST南新 | 81.7% | 行业排名> |